With tightening budgets and pharma/physician relationships coming under increasing scrutiny, the resulting pressure has impacted the success of the traditional medical conferencing model.
Novartis has struck another deal to build its position in radiopharmaceuticals, agreeing to pay $1 billion upfront for radioligand therapy (RLT) developer Mariana Oncology
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.